A Phase Ib Clinical Study of Personalized Neoantigen Peptide Vaccines for Solid Tumors
Latest Information Update: 20 Jun 2025
At a glance
- Drugs Poly ICLC (Primary) ; SQK 01 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
Most Recent Events
- 10 Jun 2025 New trial record